Micki Klearman - 11 May 2026 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Reporting relationship: Director
Issuer ticker: KZR
Reported as of: 11 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 May 2026, 16:30:33 UTC
Prior SEC filing: 23 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Marc Belsky, Attorney-in-Fact

Key filing fact

Micki Klearman filed Form 4 for Kezar Life Sciences, Inc. (KZR) on 11 May 2026.

Key facts

This page summarizes Micki Klearman's Form 4 filing for Kezar Life Sciences, Inc. (KZR).
4 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 11 May 2026, 16:30.

Change

Previous filing in this sequence was filed on 23 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001864934 Primary reporting owner

Klearman Micki

Relationship: Director
Address: C/O KEZAR LIFE SCIENCES, INC., 4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO
Signature: /s/ Marc Belsky, Attorney-in-Fact
Signature date: 11 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KZR transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -3,500
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,500
Exercise price: $26.40
Footnotes: F1

KZR transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -5,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,000
Exercise price: $6.70
Footnotes: F2

KZR transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -5,200
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,200
Exercise price: $22.80
Footnotes: F1

KZR transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -2,600
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,600
Exercise price: $22.80
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Micki Klearman is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the "Merger Agreement"), each option to acquire shares of Issuer common stock (the "Company Stock Options") that had a per share exercise price equal to or greater than $6.955 per share ("Cash Amount") (an "Out-of-the-Money Option"), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the "Merger"), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the "Effective Time") , and no consideration was delivered in exchange for such Out-of-the-Money Option.

Footnote F2

Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an "In-the-Money Option") was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money Option, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option.